Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02000713 · ClinicalTrials.gov registry record · NA
Cervical Spinal Cord Metabolism and Microstructure in Amyotrophic Lateral Sclerosis(ALS)
A NA study, sponsored by University of Michigan.
- Terminated
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT02000713 is a NA study that was terminated before completion, run by University of Michigan. The registered enrollment target is 20 participants.
The verdict
NCT02000713, a NA study, was terminated before completion, sponsored by University of Michigan.
- TERMINATED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The investigators want to know if magnetic resonance imaging can accurately provide an early diagnosis of amyotrophic lateral sclerosis (ALS).
Interventions
- OTHER MRI
- OTHER Clinical Exam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2013-10 |
| Est. Completion | 2015-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02000713
The ClinicalTrials.gov registry entry for NCT02000713 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which MRI is the first listed.
NCT02000713 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02000713 about?
NCT02000713 is a clinical study titled "Cervical Spinal Cord Metabolism and Microstructure in Amyotrophic Lateral Sclerosis(ALS)". The investigators want to know if magnetic resonance imaging can accurately provide an early diagnosis of amyotrophic lateral sclerosis (ALS).
What is the current status of trial NCT02000713?
This trial is currently terminated. It is a NA study. The enrollment target is 20 participants. The study started on 2013-10. Estimated completion is 2015-08.
What interventions are being tested in trial NCT02000713?
The interventions under investigation include: MRI (OTHER), Clinical Exam (OTHER).
Who is sponsoring clinical trial NCT02000713?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.